➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Colorcon
Johnson and Johnson
AstraZeneca

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

SODIUM FLUORIDE F-18 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Sodium Fluoride F-18, and what generic alternatives are available?

Sodium Fluoride F-18 is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, and Univ Utah Cyclotron. and is included in twenty-three NDAs.

The generic ingredient in SODIUM FLUORIDE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.

US ANDA Litigation and Generic Entry Outlook for Sodium Fluoride F-18

A generic version of SODIUM FLUORIDE F-18 was approved as sodium fluoride f-18 by SOFIE on December 26th, 2012.

  Start Trial

Summary for SODIUM FLUORIDE F-18
Drug patent expirations by year for SODIUM FLUORIDE F-18
Recent Clinical Trials for SODIUM FLUORIDE F-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of New EnglandEarly Phase 1
University of BaghdadPhase 2/Phase 3
Dow University of Health SciencesPhase 3

See all SODIUM FLUORIDE F-18 clinical trials

Pharmacology for SODIUM FLUORIDE F-18
Medical Subject Heading (MeSH) Categories for SODIUM FLUORIDE F-18

US Patents and Regulatory Information for SODIUM FLUORIDE F-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3d Imaging Drug SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203777-001 Oct 19, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Spectron Mrc Llc SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203912-001 Apr 22, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Jubilant Draximage SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203968-001 Oct 23, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Decatur SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204464-001 Oct 21, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Colorcon
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.